Dumpies, Oliver
Jobs, Alexander
Obradovic, Danilo
van Wiechen, Maarten
Hartung, Philipp
Rotta detto Loria, Johannes
Wilde, Johannes
Majunke, Nicolas
Kiefer, Philipp
Noack, Thilo
Thiele, Holger
van Mieghem, Nicolas
Desch, Steffen
Abdel-Wahab, Mohamed http://orcid.org/0000-0002-9596-558X
Funding for this research was provided by:
Universitätsklinikum Leipzig
Article History
Received: 6 November 2022
Accepted: 19 December 2022
First Online: 7 February 2023
Declarations
:
: Prof. M. Abdel-Wahab reports that his hospital receives speaker’s honoraria and/or consultancy fees on his behalf from Medtronic and Boston Scientific. Prof. N. Van Mieghem received research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Biotronik, Medtronic, Daiichi Sankyo, Abiomed, PulseCath BV, Pie Medical. All other authors have no conflicts of interest to declare.
: Patient-level data from the CHOICE-CLOSURE trial and Dumpies et al. were used in this study. The patient data from Dumpies et al. were collected as part of a dedicated institutional registry (Leipzig TAVI registry) approved by the local ethics committee. All patients provided a written informed consent. The CHOICE-CLOSURE trial was approved by the local ethics committees of all participating centers, and each patient provided written informed consent for inclusion in the trial.